Satoshi Ikeda
← Back to Kansai Medical University
Kansai Medical University
Satoshi Ikeda works in Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies. Recorded institutional associations include Kansai Medical University, Kumamoto University Hospital, Kanagawa Cardiovascular and Respiratory Center.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
2019 · 603 citationsIn situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition
2002 · 107 citationsTrabecular Bone Turnover and Bone Marrow Cell Development in Tail-Suspended Mice
1999 · 100 citationsA Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial Pneumonitis
2020 · 95 citationsUpdated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated EGFR
2022 · 93 citationsNintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial
2022 · 85 citationsA Comparison of Alfacalcidol and Menatetrenone for the Treatment of Bone Loss in an Ovariectomized Rat Model of Osteoporosis
2002 · 74 citationsSerum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease
2017 · 70 citationsReal‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L
2021 · 70 citationsSerum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status
2017 · 65 citationsSafety and efficacy of S-1 in combination with carboplatin in non-small cell lung cancer patients with interstitial lung disease: a pilot study
2016 · 57 citationsInterstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
2015 · 52 citationsPulmonary granulomas caused experimentally in mice by a recombinant trigger-factor protein of Propionibacterium acnes.
2003 · 51 citationsIncidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study
2015 · 50 citationsSummary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia
2019 · 50 citationsIntermittent Administration of Human Parathyroid Hormone(1–34) Prevents Immobilization-Related Bone Loss by Regulating Bone Marrow Capacity for Bone Cells in ddY Mice
1999 · 49 citationsA Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC
2021 · 49 citationsDetection of gene point mutation in paraffin sections using in situ loop‐mediated isothermal amplification
2007 · 47 citationsPredictive Factors for the Long-Term Deterioration of Pulmonary Function in Interstitial Lung Disease Associated with Anti-Aminoacyl-tRNA Synthetase Antibodies
2018 · 47 citationsLow body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis
2017 · 44 citationsA multicenter cohort study of osimertinib compared with afatinib as first-line treatment for EGFR-mutated non-small-cell lung cancer from practical dataset: CJLSG1903
2021 · 43 citationsEffects of atrial natriuretic peptide on inter-organ crosstalk among the kidney, lung, and heart in a rat model of renal ischemia-reperfusion injury
2014 · 36 citationsOutcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases
2020 · 36 citationsBiomarker Testing in Patients With Unresectable Advanced or Recurrent Non–Small Cell Lung Cancer
2023 · 36 citationsSerial changes in negative T wave on electrocardiogram in acute pulmonary thromboembolism
1999 · 34 citations
